CAMBRIDGE, Mass.--(BUSINESS WIRE)--Agios Pharmaceuticals, the leading biopharmaceutical company focused on discovering and developing novel drugs in the field of cancer metabolism, today announced that David Schenkein, M.D., chief executive officer, is scheduled to present at the Cowen and Company 32nd Annual Health Care Conference on Wednesday, March 7, 2012 at 10:30AM EST at the Boston Marriott Copley Place.
